Bluebird Bio announced Friday it would sell itself and its portfolio of gene therapies to the investment firms Carlyle and SK ...
Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.
There is a catch. If the private equity firms can boost sales of bluebird’s three gene therapies to $600 million—over any ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Company says it received conditional approval for bird flu vaccine from US Department of Agriculture
CNN reached out to the USDA for comment Sunday. While other countries already vaccinate chickens against bird flu, the US approach has long been focused on eradicating the virus, mainly through ...
Gene therapy maker bluebird bio on Friday agreed to be taken private by Carlyle and SK Capital Partners at a discount, ending ...
Check out our top picks from Steam Next Fest October 2024 for an idea of what to expect when the next sale arrives. The best Steam feature for keeping track of sales is your wishlist. Browsing ...
As bluebird bio struggles to get its gene therapies ... and the biotech is looking at a number of options including the possible sale of priority review vouchers that it could receive from the ...
The best 4K Blu-ray players deliver the ultimate picture quality for watching movies and TV series at home. Although streaming services are popular, Blu-rays deliver video at a higher bitrate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback